A
Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
Price:
7.03
USD
-2.5%
Market Closed
Market Cap:
$1.5B
Relative Value
The Relative Value of one AVAH stock under the Base Case scenario is 12.48 USD. Compared to the current market price of 7.03 USD, Aveanna Healthcare Holdings Inc is Undervalued by 44%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AVAH
Relative Value
Base Case
12.48
USD
Undervaluation 44%
A
Multiples Across Competitors
AVAH Competitors Multiples
Aveanna Healthcare Holdings Inc Competitors
Aveanna Healthcare Holdings Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
A
|
Aveanna Healthcare Holdings Inc
NASDAQ:AVAH
|
1.5B USD | 0.6 | 19.5 | 11.4 | 11.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
96.2B USD | 0.2 | 54.4 | 13.9 | 13.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
66B EUR | 0.3 | 12.9 | 7.6 | 9.6 | |
| US |
|
Cigna Corp
NYSE:CI
|
68.7B USD | 0.3 | 11.5 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.4B EUR | 1.2 | 20.8 | 9.8 | 14.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 1.2 | 23.6 | 9.1 | 16.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.2B USD | 1.6 | 25.3 | 12.2 | 17.7 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.1B USD | 2 | 22.4 | 12.4 | 16.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 0.6 | 11.3 | 5.4 | 10 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.5B USD | 11.7 | -27.6 | -29.7 | -27 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 0.8 | 14.2 | 7.4 | 10 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
